KLCM Advisors Inc. Buys 5,515 Shares of The Clorox Company $CLX

KLCM Advisors Inc. lifted its stake in The Clorox Company (NYSE:CLX) by 43.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,230 shares of the company’s stock after purchasing an additional 5,515 shares during the quarter. KLCM Advisors Inc.’s holdings in Clorox were worth $1,889,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of CLX. Kornitzer Capital Management Inc. KS raised its holdings in Clorox by 2.1% in the first quarter. Kornitzer Capital Management Inc. KS now owns 199,915 shares of the company’s stock worth $20,717,000 after buying an additional 4,102 shares during the last quarter. Main Street Research LLC grew its holdings in shares of Clorox by 4.5% during the first quarter. Main Street Research LLC now owns 9,537 shares of the company’s stock valued at $988,000 after buying an additional 412 shares during the last quarter. Kestra Advisory Services LLC grew its holdings in shares of Clorox by 15.4% during the first quarter. Kestra Advisory Services LLC now owns 31,820 shares of the company’s stock valued at $3,297,000 after buying an additional 4,252 shares during the last quarter. Money Concepts Capital Corp increased its position in shares of Clorox by 25.9% during the first quarter. Money Concepts Capital Corp now owns 8,389 shares of the company’s stock valued at $869,000 after acquiring an additional 1,725 shares in the last quarter. Finally, Resona Asset Management Co. Ltd. raised its holdings in Clorox by 2.7% in the 1st quarter. Resona Asset Management Co. Ltd. now owns 62,929 shares of the company’s stock worth $6,491,000 after acquiring an additional 1,636 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Performance

NYSE CLX traded up $3.50 on Friday, reaching $96.57. 2,188,531 shares of the stock were exchanged, compared to its average volume of 2,152,430. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The Clorox Company has a one year low of $84.70 and a one year high of $132.03. The firm has a market capitalization of $11.68 billion, a PE ratio of 15.68, a PEG ratio of 0.44 and a beta of 0.54. The company’s 50-day simple moving average is $94.10 and its two-hundred day simple moving average is $104.07.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue was up .1% on a year-over-year basis. During the same period in the prior year, the business posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts expect that The Clorox Company will post 5.53 EPS for the current fiscal year.

Insider Activity

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CLX shares. TD Cowen upped their price objective on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research report on Tuesday, March 31st. JPMorgan Chase & Co. decreased their price target on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Citigroup dropped their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Finally, Royal Bank Of Canada cut their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a report on Thursday, April 9th. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, Clorox has an average rating of “Reduce” and a consensus price target of $103.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.